shopping cart Your cart is empty
  • Home
  • Medical Devices
  • Artificial Ventilation And Anesthesia Mask Market By Application (High Risk Procedures, Standard Risk Procedures, Moderate Risk Pr...

Artificial Ventilation And Anesthesia Mask Market By Application (High Risk Procedures, Standard Risk Procedures, Moderate Risk Procedures), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: May 5, 2016

Key findings


The global artificial ventilation and anesthesia mask marketis expected to grow at the CAGR of 4.8% during 2015-2022. The major factors that are driving theglobalartificial ventilation and anesthesia mask market are the raising number of operation and emergency room procedures, increasing geriatric population and growing prevalence of sleep apnea. As far as region is concerned, North America dominated the overall market with a share of more than 50%in 2014. In AsiaPacific, artificial ventilation and anesthesia mask market is expected to grow with an impressive pace during 2015-2022 due to technological upgradation, increase in public and private healthcare sector, rising income level and changing lifestyle etc. Although there are many factors which are the key drivers of the market but still there are certain challenges which the market has to overcome. Such challenges include emergence of new players with novel products offerings such as SuperNO2VA from RMDevices, is expected to change the market dynamics. The RM devices are designed in such a way that they improve patient safety at the same time reduces the costs per procedures at the hospitals., also it has got the ability to carry out inhalation anesthesia, artificial ventilation and incubation procedure simultaneously


Market segment insight


The market is mainly segmented on the basis of application which includes High Risk Procedures; Standard Risk Procedures and Moderate Risk Procedures .On the basis of Moderate Risk Procedures the market is segmented intoIntensive Care Units, Operation Room, Emergency Room and dental.In 2014 operating room held maximum share of over 58% for low risk procedures and is expected to be largest segment in the next seven years.


Regional insight


Based on this type, the market is segmented into North America, Europe, APAC and RoW. North America dominated the overall market with a share of more than 50%in 2014. Key factors attributing to its large share includes, presence of robust healthcare infrastructure which includes hospitals, dental care and emergency. Asia pacificis the fastest growing region owing to increase in public and private healthcare sector.


Competitive insight


Some of the major market players areResMed, Fisher and Paykel, Ambu, Drager, and CareFusion. Phillips Respironics is market leader as it has very strong financial performance, wide product portfolio and it also ranks very high on regional penetration. Some of its key products are Wisp, ComfortGel blue nasal mask, Amara full view mask, and Easy life CPAP masks.

CHAP 1. METHODOLOGY & SCOPE 13
1.1. RESEARCH METHODOLOGY 13
1.2. RESEARCH SCOPE & ASSUMPTIONS 13
1.3. LIST OF DATA SOURCES 13


CHAP 2. EXECUTIVE SUMMARY 14
2.1. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET SUMMARY & KEY BUYING CRITERIA 14
2.2. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET OUTLOOK 14
2.3. MARKET SEGMENTATION ANALYSIS 14
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 14
2.5. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET VALUE CHAIN ANALYSIS 14
2.6. VENDOR LANDSCAPE 14


CHAP 3. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET 15
3.1. MARKET DRIVER ANALYSIS 15
3.1.1. RISING NUMBER OF OPERATION AND EMERGENCY ROOM PROCEDURES 15
3.1.2. INCREASING GERIATRIC POPULATION 15
3.1.3. GROWING PREVALENCE OF SLEEP APNEA 15
3.2. MARKET RESTRAINT ANALYSIS 15
3.2.1. LACK OF PATIENT COMPLIANCE 15
3.2.2. STRINGENT GOVERNMENT REGULATIONS 15
3.3. KEY OPPORTUNITIES 15
3.3.1. INCREASING GERIATRIC POPULATION LEADING TO THE RISE OF PREVELANCE RATE OF SEVERAL DISEASES 15
3.3.2. HIGH DEMAND FOR ICU AND OPERATING ROOM PROCEDURES 15
3.4. CHALLENGES 15
3.4.1. EMERGENCE OF NEW PLAYERS WITH NOVEL PRODUCT 15
3.4.2. LACK OF SKILLED PROFFESIONAL 15


CHAP 4. INDUSTRY ANALYSIS 16
4.1. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET– PORTER’S FIVE FORCE MODEL 16
4.2. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET– PESTEL ANALYSIS 16
4.3. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET– GAP ANALYSIS 16


CHAP 5. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY APPLICATION 2012-2022 ($ BILLION) 17
5.1. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY HIGH RISK PROCEDURES 2012-2022 ($ BILLION) 17
5.1.1. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY INTENSIVE CARE UNITS 2012-2022 ($ BILLION) 17
5.1.2. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY OPERATION ROOM 2012-2022 ($ BILLION) 17
5.1.3. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY EMERGENCY ROOM 2012-2022 ($ BILLION) 17
5.1.4. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY DENTAL 2012-2022 ($ BILLION) 17
5.2. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY STANDARD RISK PROCEDURES 2012-2022 ($ BILLION) 17
5.2.1. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY INTENSIVE CARE UNITS 2012-2022 ($ BILLION) 17
5.2.2. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY OPERATION ROOM 2012-2022 ($ BILLION) 17
5.2.3. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY EMERGENCY ROOM 2012-2022 ($ BILLION) 18
5.2.4. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY DENTAL 2012-2022 ($ BILLION) 18
5.3. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY MODERATE RISK PROCEDURES 2012-2022 ($ BILLION) 18
5.3.1. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY INTENSIVE CARE UNITS 2012-2022 ($ BILLION) 18
5.3.2. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY OPERATION ROOM 2012-2022 ($ BILLION) 18
5.3.3. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY EMERGENCY ROOM 2012-2022 ($ BILLION) 18
5.3.4. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY DENTAL 2012-2022 ($ BILLION) 18


CHAP 6. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET, REGIONAL OUTLOOK 2012-2022($ BILLION) 19
6.1. GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY REGION 2012-2022 ($ BILLION) 19
6.2. NORTH AMERICA 19
6.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
6.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
6.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
6.2.3.1. U.S. 19
6.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
6.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
6.2.3.2. CANADA 19
6.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
6.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
6.2.3.3. MEXICO 19
6.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
6.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
6.3. EUROPE 20
6.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
6.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
6.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
6.3.3.1. GERMANY 20
6.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
6.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
6.3.3.2. UK 20
6.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
6.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
6.3.3.3. FRANCE 20
6.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
6.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
6.3.3.3.3. SPAIN 21
6.3.3.3.4. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
6.3.3.3.5. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
6.3.3.3.6. ITALY 21
6.3.3.3.7. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
6.3.3.3.8. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
6.3.3.4. REST OF EUROPE 21
6.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 21
6.3.3.4.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 21
6.4. ASIA PACIFIC 21
6.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
6.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 21
6.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
6.4.3.1. CHINA 21
6.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
6.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
6.4.3.2. INDIA 21
6.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
6.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
6.4.3.3. JAPAN 22
6.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
6.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 22
6.4.3.4. AUSTRALIA 22
6.4.3.4.1. AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
6.4.3.4.2. AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 22
6.4.3.5. OTHERS 22
6.4.3.5.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 22
6.4.3.5.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 22
6.5. REST OF THE WORLD 22
6.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
6.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
6.5.3. SOUTH AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
6.5.4. SOUTH AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22


CHAP 7. COMPETITIVE LANDSCAPE 23
7.1. AIR LIQUIDE HEALTHCARE 24
7.1.1. COMPANY OVERVIEW 24
7.1.2. SCOT ANALYSIS 24
7.1.3. PRODUCT BENCHMARKING 24
7.1.4. STRATEGIC INITIATIVES 24
7.2. CAREFUSION 24
7.2.1. COMPANY OVERVIEW 24
7.2.2. SCOT ANALYSIS 24
7.2.3. PRODUCT BENCHMARKING 24
7.2.4. STRATEGIC INITIATIVES 24
7.3. FISHER & PAYKEL HEALTHCARE 24
7.3.1. COMPANY OVERVIEW 24
7.3.2. SCOT ANALYSIS 24
7.3.3. PRODUCT BENCHMARKING 24
7.3.4. STRATEGIC INITIATIVES 24
7.4. DRAGER 24
7.4.1. COMPANY OVERVIEW 24
7.4.2. SCOT ANALYSIS 24
7.4.3. PRODUCT BENCHMARKING 24
7.4.4. STRATEGIC INITIATIVES 24
7.5. HOFFRICHTER GMBH 24
7.5.1. COMPANY OVERVIEW 24
7.5.2. SCOT ANALYSIS 24
7.5.3. PRODUCT BENCHMARKING 24
7.5.4. STRATEGIC INITIATIVES 24
7.6. PHILLIPS 24
7.6.1. COMPANY OVERVIEW 24
7.6.2. SCOT ANALYSIS 25
7.6.3. PRODUCT BENCHMARKING 25
7.6.4. STRATEGIC INITIATIVES 25
7.7. RESMED 25
7.7.1. COMPANY OVERVIEW 25
7.7.2. SCOT ANALYSIS 25
7.7.3. PRODUCT BENCHMARKING 25
7.7.4. STRATEGIC INITIATIVES 25
7.8. AMBU 25
7.8.1. COMPANY OVERVIEW 25
7.8.2. SCOT ANALYSIS 25
7.8.3. PRODUCT BENCHMARKING 25
7.8.4. STRATEGIC INITIATIVES 25
7.9. GALEMED 25
7.9.1. COMPANY OVERVIEW 25
7.9.2. SCOT ANALYSIS 25
7.9.3. PRODUCT BENCHMARKING 25
7.9.4. STRATEGIC INITIATIVES 25
7.10. ACUTRONIC MEDICAL SYSTEMS 25
7.10.1. COMPANY OVERVIEW 25
7.10.2. SCOT ANALYSIS 25
7.10.3. PRODUCT BENCHMARKING 25
7.10.4. STRATEGIC INITIATIVES 25
7.11. ABBOT LABORATORIES 25
7.11.1. COMPANY OVERVIEW 25
7.11.2. SCOT ANALYSIS 25
7.11.3. PRODUCT BENCHMARKING 26
7.11.4. STRATEGIC INITIATIVES 26
7.12. ASPECT MEDIAL SYESTEMS 26
7.12.1. COMPANY OVERVIEW 26
7.12.2. SCOT ANALYSIS 26
7.12.3. PRODUCT BENCHMARKING 26
7.12.4. STRATEGIC INITIATIVES 26
7.13. COVIDIEN PLC 26
7.13.1. COMPANY OVERVIEW 26
7.13.2. SCOT ANALYSIS 26
7.13.3. PRODUCT BENCHMARKING 26
7.13.4. STRATEGIC INITIATIVES 26
7.14. LMA INTERNATIONAL INC 26
7.14.1. COMPANY OVERVIEW 26
7.14.2. SCOT ANALYSIS 26
7.14.3. PRODUCT BENCHMARKING 26
7.14.4. STRATEGIC INITIATIVES 26
7.15. SUNRISE MEDICAL.INC 26
7.15.1. COMPANY OVERVIEW 26
7.15.2. SCOT ANALYSIS 26
7.15.3. PRODUCT BENCHMARKING 26
7.15.4. STRATEGIC INITIATIVES 26

TABLE 1 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 2 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY HIGH RISK PROCEDURES 2012-2022 ($ BILLION) 27
TABLE 3 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY INTENSIVE CARE UNITS 2012-2022 ($ BILLION) 27
TABLE 4 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY OPERATION ROOM 2012-2022 ($ BILLION) 27
TABLE 5 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY EMERGENCY ROOM 2012-2022 ($ BILLION) 27
TABLE 6 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY DENTAL 2012-2022 ($ BILLION) 27
TABLE 7 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY STANDARD RISK PROCEDURES 2012-2022 ($ BILLION) 27
TABLE 8 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY INTENSIVE CARE UNITS 2012-2022 ($ BILLION) 27
TABLE 9 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY OPERATION ROOM 2012-2022 ($ BILLION) 27
TABLE 10 GLOBAL ARTIFICIAL VENTILATION AND ANESTHESIA MASK MARKET BY REGION 2012-2022 ($ BILLION) 27
TABLE 11 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 12 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 27
TABLE 13 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 27
TABLE 14 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 15 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 27
TABLE 16 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 17 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 27
TABLE 18 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 19 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 20 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 21 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 28
TABLE 22 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 23 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 24 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 25 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 26 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 27 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 28 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 29 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 30 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 31 ITALY MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 28
TABLE 32 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 33 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 28
TABLE 34 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 35 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 28
TABLE 36 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 37 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 38 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 39 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 40 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 41 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 42 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 29
TABLE 43 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 44 AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 29
TABLE 45 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 29
TABLE 46 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 29
TABLE 47 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 48 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 49 SOUTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29

FIGURE 1 MARKET SHARE BY REGIONS 29
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 10 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 11 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 15 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 16 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 17 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 18 SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)